Latest Announcements

BSE & NSE corporate filings with AI summaries

NSERecord DateResults4 Aug 2026

Morepen Laboratories Limited

Record Date

Morepen Laboratories Limited has informed the Exchange that Record date for the purpose of Final Dividend is 19-Sep-2026. The company has also approved the financial results for the quarter ended 30th June 2026, and has announced the re-appointment of Mr. Sushil Suri as the Chairman & Managing Director of the company.

Read more →📎 1 attachment
NSEShareholders meetingResults4 Aug 2026

Butterfly Gandhimathi Appliances Limited

Shareholders meeting

Butterfly Gandhimathi Appliances Limited held its 39th Annual General Meeting through video conferencing on August 4, 2026, in compliance with relevant circulars and applicable provisions. The meeting considered the adoption of audited financial statements, appointment of a director, and ratification of remuneration payable to cost auditors.

Read more →📎 1 attachment
NSEOutcome of Board Meeting▲ PositiveResults4 Aug 2026

Alembic Pharmaceuticals Limited

Outcome of Board Meeting

Alembic Pharmaceuticals Limited has submitted its financial results for the quarter ended June 30, 2026, with the Board of Directors approving the consolidated and standalone unaudited financial results along with the Limited Review Report issued by the Statutory Auditors.

Read more →📎 1 attachment
NSEOutcome of Board Meeting▲ PositiveResults4 Aug 2026

Wonderla Holidays Limited

Outcome of Board Meeting

Wonderla Holidays Limited has submitted its financial results for the quarter ended June 30, 2026, with a profit before tax of Rs. 9,346.54 lakhs and a total revenue of Rs. 25,210.21 lakhs. The company has also allotted 15,105 shares to employees and granted 8,980 stock options to two employees.

Read more →📎 1 attachment
NSEInvestor Presentation▲ PositiveResults4 Aug 2026

Repro India Limited

Investor Presentation

Repro India Limited has informed the Exchange about Investor Presentation, showcasing Q1 FY27 performance highlights, including 20% YoY revenue growth, stable gross margins, and exceptional gain from Mahape land sale.

Read more →📎 1 attachment
NSEInvestor Presentation▲ PositiveResults4 Aug 2026

Emami Limited

Investor Presentation

Emami Limited reported a 15% topline growth in Q1FY27, with consolidated revenues reaching ₹1,039 crore. Domestic Business grew 20%, while International Business declined 12% due to West Asia disruptions. EBITDA grew 6% to ₹226 crore despite higher input costs.

Read more →📎 1 attachment
NSEOutcome of Board MeetingResults4 Aug 2026

Summit Securities Limited

Outcome of Board Meeting

Summit Securities Limited has submitted its unaudited financial results for the quarter ended June 30, 2026, as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Read more →📎 1 attachment
NSEPress Release▲ PositiveResults4 Aug 2026

Emami Limited

Press Release

Emami Limited has reported a 15% topline growth in Q1FY27, with domestic business growing 20% and international business declining 12% due to West Asia disruptions. The company has also made strategic investments to strengthen its future growth portfolio.

Read more →📎 1 attachment
NSEPress Release▲ PositiveResults4 Aug 2026

Morepen Laboratories Limited

Press Release

Morepen Laboratories Limited has announced its financial results for Q1 FY27, reporting its highest-ever quarterly revenue and earnings, supported by better operating leverage, improved performance on API front, strong export growth and full scale commercialization of CDMO mandate.

Read more →📎 1 attachment
NSEAnalysts/Institutional Investor Meet/Con. Call UpdatesResults4 Aug 2026

Zim Laboratories Limited

Analysts/Institutional Investor Meet/Con. Call Updates

Zim Laboratories Limited has informed the Exchange about the schedule of a Q1FY27 Earnings Conference Call to be held on Friday, 07th August, 2026 at 12:00 p.m. IST. The call will be hosted by Go India Advisors and will feature company participants Mr. Zulfiquar Kamal, Mr. Shyam Mohan Patro, and Mr. Zain Daud.

Read more →📎 1 attachment
NSEInvestor Presentation▲ PositiveResults4 Aug 2026

Indian Metals & Ferro Alloys Limited

Investor Presentation

Indian Metals & Ferro Alloys Ltd (IMFA) reported record revenue and robust financial performance in Q1 FY27, driven by higher ferro chrome output and firm prices. The company's Greenfield Expansion Project at Kalinganagar is on track, with the first furnace expected to be commissioned in August 2026 and the second furnace in September 2026. IMFA has also signed a long-term offtake arrangement with Enfinity Global for an additional 65 MWp hybrid renewable energy, expected to be available by June 2027.

Read more →📎 1 attachment
NSEOutcome of Board Meeting▲ PositiveResults4 Aug 2026

Dr. Agarwal's Health Care Limited

Outcome of Board Meeting

Dr. Agarwal's Health Care Limited announced its unaudited consolidated financial results for the quarter ended June 30, 2026, with revenue from operations growing by 26.0% YoY to ₹614 Crores, total income growing by 23.9% YoY to ₹620 Crores, IND-AS EBITDA growing by 25.2% YoY to ₹177 Crores, and PAT growing by 44.6% YoY to ₹55 Crores.

Read more →📎 1 attachment
NSEPress Release▲ PositiveResults4 Aug 2026

Indian Metals & Ferro Alloys Limited

Press Release

Indian Metals & Ferro Alloys Ltd (IMFA) has announced its Q1 FY2027 earnings, reporting a record revenue of ₹960.45 crore, up 50% from ₹641.54 crore in Q1 FY26, driven by higher ferro chrome output and firm prices. The company's EBITDA and PAT also saw significant increases, to ₹281.27 crore and ₹191.49 crore, respectively. IMFA's Greenfield Expansion Project at Kalinganagar (KNR 1) is on track, with the first furnace expected to be commissioned in August 2026 and the second furnace in September 2026. The company has also signed a long-term offtake arrangement with Enfinity Global for an additional 65 MWp hybrid renewable energy, which will contribute to its green footprint.

Read more →📎 1 attachment
NSEPress Release▲ PositiveResults4 Aug 2026

Capillary Technologies India Limited

Press Release

Capillary Technologies India Limited has announced its financial results for the first quarter ended June 30, 2026, with a 43% year-on-year growth in operating revenue and a 132% year-on-year growth in adjusted EBITDA. The company reported strong profitability metrics with normalized profit after tax (PAT) growing exponentially (+3,320%) driven by operational efficiencies and integration synergies across the acquired businesses.

Read more →📎 1 attachment
← PreviousPage 1196 of 1575Next →